Anadys Forms Collaboration With Gilead

Anadys Pharmaceuticals, Inc. and Gilead Sciences, Inc. have entered into a collaboration to discover novel antiviral compounds. As part of the collaboration agreement, Anadys will design, configure and run uHTS-ATLAS screens against a key viral target selected by Gilead. This agreement leverages Anadys’ powerful ability to screen for small molecules that bind to proteins that Read more about Anadys Forms Collaboration With Gilead[…]

Cerylid, Anadys Sign Anti-infective Collaboration

Cerylid Biosciences Limited and Anadys Pharmaceuticals, Inc. have announced a strategic partnership for the discovery of novel anti-infective compounds. This partnership will utilize Anadys’ uHTS-ATLAS technology to screen Cerylid’s world leading collection of natural products against key Anadys targets. Under the terms of the collaboration, Anadys will gain access to Cerylid’s extensive library of unique Read more about Cerylid, Anadys Sign Anti-infective Collaboration[…]


Virologic Expands Pact With Pfizer

ViroLogic Inc. has signed an expanded agreement with Pfizer Inc. to use ViroLogic’s HIV resistance testing technology for Pfizer’s HIV drug discovery and development programs.ViroLogic said the new pact covers work performed for all of Pfizer’s global research and development sites worldwide. As recommended by the FDA’s antiviral drugs advisory committee, biopharmaceutical companies are using Read more about Virologic Expands Pact With Pfizer[…]

Anadys And Sequoia Sciences Announce Drug Discovery Collaboration

Anadys Pharmaceuticals, Inc. and Sequoia Sciences, Inc. have entered into a drug discovery collaboration to identify novel anti-infectives. This partnership will harness Sequoia’s unique library of compounds isolated from natural products using the fully integrated drug discovery capabilities of Anadys. Under the terms of the agreement, Anadys will deploy its proprietary screening technologies uHTS-ATLAS and Read more about Anadys And Sequoia Sciences Announce Drug Discovery Collaboration[…]

International Therapeutics Announces Collaboration With City Of Hope

International Therapeutics, Inc. has entered into a Collaborative Research Agreement with City of Hope National Medical Center and Beckman Research Institute (Duarte, CA), to evaluate and characterize novel small interfering RNA (siRNA) molecules against HIV. siRNA are short anti-sense (mirror image) oligonucleotides that exert their effect by causing messenger RNA degradation, and in turn, inhibit Read more about International Therapeutics Announces Collaboration With City Of Hope[…]

Microcide Signs Research Collaboration

Microcide Pharmaceuticals, Inc. has entered into a research collaborative agreement with Discovery Partners International, Inc., to optimise the drug-like qualities of Microcide’s recently discovered broad-spectrum antifungal compound series. Using Microcide’s proprietary microbial genomics VALID System, the Company has discovered and developed a series of promising antifungal compounds to the point of lead optimisation. Members of Read more about Microcide Signs Research Collaboration[…]

Schering And MediGene Collaborate On Human Papilloma Virus Treatment

Schering AG and MediGene AG has announced the formation of a world-wide strategic alliance to develop and commercialise MediGene’s Viral Vaccine for the treatment of precancerous lesions of the cervix caused by human papilloma viruses (HPV). Schering has been granted a world-wide exclusive license with the right to grant sublicenses. MediGene has an option for Read more about Schering And MediGene Collaborate On Human Papilloma Virus Treatment[…]

abbott laboratories

Collaborative Group And Abbott Sign License Agreement

The Collaborative Group, Ltd., and Abbott Laboratories have signed a worldwide, exclusive license agreement granting Abbott access to Collaborative’s technology relating to fungal beta (1,3)-glucan detection reagents for human fungal diagnostic assay development and commercialization. The technology allows easy integration with a variety of diagnostic assay formats, and also provides improved performance over other existing Read more about Collaborative Group And Abbott Sign License Agreement[…]

PowderJect Completes Acquisition Of Medeva Vaccines

PowderJect Pharmaceuticals PLC has announced that following authorization by its shareholders at the company’s Extraordinary General Meeting on Friday September 29, it has completed its acquisition of Medeva’s vaccines business from Celltech Group Plc. The acquisition includes a range of marketed vaccines, which will be sold under the established Evans Vaccines brand, and one of Read more about PowderJect Completes Acquisition Of Medeva Vaccines[…]